Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2007
12/04/2007US7303886 High throughput cell-based functional assays and using cells, e.g., HEK-293 cells that express a G protein such as G alpha 15, G alpha 16 or gustducin.
12/04/2007US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007US7303877 Using trangenic fungus to produce heterologous proteins; bioreactors
12/04/2007US7303873 Tobacco enhancer sequences identified using promoterless glucuronidase vector; genetic engineering and gene expression
12/04/2007US7303871 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating damaging effects of gluten
12/04/2007US7303868 Mutant bank
12/04/2007US7303814 Immobilized bioactive hydrogel matrices as surface coatings
12/04/2007US7303754 MVA expressing modified HIV envelope, gag, and pol genes
12/04/2007US7303751 P. falciparum erythrocyte binding protein-2 (EBP2) Region II (RII), used to induce an immune response to Plasmodium falciparum merozoites to treat diseases such as malaria
12/04/2007US7303748 Locally administering an effective amount of an agent capable of blocking or inhibiting vascular endothelial growth factor (VEGF)-mediated activity to a subject in need thereof, such that the eye injury is ameliorated or improved, wherein the agent is VEGFR1R2-Fc Delta C1(a) (SEQ ID NO:2)
12/04/2007US7303747 Use of VEGF inhibitors for treatment of eye disorders
12/04/2007US7303746 Methods of treating eye disorders with modified chimeric polypeptides
12/04/2007US7303646 Joining two surfaces; applying alkaline solution of bioadhesive; curing
12/04/2007CA2443929C Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry
12/04/2007CA2395453C Plant lesion formation suppressing gene, spl7 and use thereof
12/04/2007CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
12/04/2007CA2262647C Methods for regulating gastrointestinal motility
12/04/2007CA2224724C Subunit vaccine against flavivirus infection
12/04/2007CA2177976C Compositions and kits for fluorescence polarization assay of large molecules
12/04/2007CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them
12/04/2007CA1341565C Protection of plants against viral infection
12/04/2007CA1341563C Dna coding for human fibroblast interferon polypeptide and recombinant plasmid
11/2007
11/29/2007WO2007137152A2 Composite structure
11/29/2007WO2007137099A2 Double layer carbon nanotube-based structures and methods for removing heat from solid-state devices
11/29/2007WO2007136882A2 Radiating element for radar array antenna
11/29/2007WO2007136877A2 Delta-5 desaturase and its use in making polyunsaturated fatty acids
11/29/2007WO2007136876A2 Delta-5 desaturase from peridinium sp. and its use in making polyunsaturated fatty acids
11/29/2007WO2007136837A2 Prostate epithelial androgen receptor suppresses prostate growth and tumor invasion
11/29/2007WO2007136685A2 Methods and compositions for inactivation of dihydrofolate reductase
11/29/2007WO2007136671A2 Delta5 desaturase and its use in making polyunsaturated fatty acids
11/29/2007WO2007136646A2 Delta5 desaturase and its use in making polyunsaturated fatty acids
11/29/2007WO2007136585A2 Immunotherapeutic compositions and methods
11/29/2007WO2007136295A2 Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application
11/29/2007WO2007136133A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family
11/29/2007WO2007135958A1 System for cell surface layer expression of gram-negative bacterium
11/29/2007WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy
11/29/2007WO2007135685A2 Compositions for silencing the expression of gibberellin 2-oxidase and uses thereof
11/29/2007WO2007135420A2 Defective interfering virus
11/29/2007WO2007134906A1 Interferon-beta gene therapy using an improved, regulated expression system
11/29/2007WO2007134817A1 Biocatalysts and process for the preparation of organic compounds
11/29/2007WO2007134800A1 Ethanol dependence of alpha1 antitrypsin c-terminal lys truncation by basic carboxypeptidases
11/29/2007WO2007134539A1 Antibody to autoantigen and/or species high conservation antigen and its preparing method
11/29/2007WO2007113009A3 Ompa polypeptides of rickettsia helvetica, polynucleotides encoding therefor and use in the detection of rickettsia helvetica
11/29/2007WO2007111931A3 Compositions and methods relating to modulation of immune system components
11/29/2007WO2007106799A3 Multivalent clostridial toxins
11/29/2007WO2007106744A3 Anti-5t4 antibodies and uses thereof
11/29/2007WO2007105461A3 Gene encoding protein responsible for flocculation property of yeast and use thereof
11/29/2007WO2007100248A3 Adir related polymorphisms and applications thereof
11/29/2007WO2007093807A3 Apoptosis methods, genes and proteins
11/29/2007WO2007091881A3 Methods and means for detection of mycobacterium leprae infections
11/29/2007WO2007088460A3 Tgf-beta modulators and use thereof
11/29/2007WO2007084977A3 Low hemoglobin concentration cell percentage and method of use in detection of iron deficiency
11/29/2007WO2007084583A3 Soluble fragments of the sars-cov spike glycoprotein
11/29/2007WO2007061657A3 Interleukin-10 compositions for the treatment of adenocarcinomas
11/29/2007WO2007059513A3 Compositions and methods for modulating hemostasis
11/29/2007WO2007052326A3 Method for conversion of uric acid to allantoin and related enzymes
11/29/2007WO2007044115A3 Improved chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
11/29/2007WO2007042241A3 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications
11/29/2007WO2007039606A3 Insulin receptor antagonists and related compositions, uses and methods
11/29/2007WO2007034465A3 Use of il-1f5 for the modulation of an immune-mediated response
11/29/2007WO2007019062A3 Zinc finger binding domains for cnn
11/29/2007WO2006138572A3 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
11/29/2007WO2006130127A3 The dmi1 gene encodes a protein that is required for the early steps of bacterial and fungal symbiosis
11/29/2007WO2006107183A9 Mussel bioadhesive
11/29/2007WO2005044196A3 Novel modulators of amyloid-beta production and uses thereof
11/29/2007WO2004066958A3 Caspase-9:bir3 domain of xiap complexes and methods of use
11/29/2007WO2004052097A3 Bacterial bioherbicide for control of grassy weeds
11/29/2007WO2004037202A3 Gb virus c and methods of treating viral infections
11/29/2007WO2003093451A3 Transposable elements in rice and methods of use
11/29/2007US20070277269 Transgenic organisms with increased overall yield, increased yield of biomass or chemical components; genetic engineering; producing a plant tissue by growing a plant cell comprising an exogenous nucleic acid
11/29/2007US20070277267 Nucleic acid molecules and other molecules associated with plants
11/29/2007US20070277265 System for functional gene discovery in plants
11/29/2007US20070277258 Nucleic acid molecules and other molecules associated with plants
11/29/2007US20070277252 Transgenic Non-Human Mammal Comprising A Polynucleotide Encoding Human Or Humanized C5ar
11/29/2007US20070276131 Continuous Process for the Assembly of Macromolecular Substances and the Subsequent Capture and Isolation of Mamacromolecular Assembly and a System Suitable for the Process
11/29/2007US20070276130 Rotavirus antigens
11/29/2007US20070276128 Stabilized Proteins with Engineered Disulfide Bonds
11/29/2007US20070276127 Protein composition obtained from a muscle source
11/29/2007US20070276126 Cell adhesion and extracellular matrix proteins
11/29/2007US20070276125 Methods for inhibiting immune complex formation in a subject
11/29/2007US20070276124 Protein Expression
11/29/2007US20070276123 Amyloid Formation
11/29/2007US20070275924 Synthetic Lipid Rafts and Methods of Use
11/29/2007US20070275918 Induction of Cellular Senescence by Cdk4 Disruption for Tumor Suppression and Regression
11/29/2007US20070275916 Methods of Identifying Compounds Which Modulate Granulocite-Colony Stimulating Factor (G-Csf) Dependent Processes by Modulation of the Levels of Suppressor of Cytokine Signaling (Socs)
11/29/2007US20070275915 Tmprss2 Regulatory Sequences and Uses Thereof
11/29/2007US20070275914 Therapeutic Compositions
11/29/2007US20070275901 Synthesis, modification and reduction of primary structure of hypotensive peptides present in scorpion venom for optimizing their use as a hypotensive medicament
11/29/2007US20070275899 Treatment Of Demyelinating Autoimmune Disease with Modified Ordered Peptides
11/29/2007US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007US20070275892 Modulating stroma-cell-derived-factor (SDF-1) receptor activity in hematopoietic stem cells, hematopoietic progenitor cells, primitive granulocytes, primitive erythroid cells, leukocytes, and neutrophils; reducing ability to act as substrate to amino/carboxypeptidases
11/29/2007US20070275891 OBG3 globular head and uses thereof
11/29/2007US20070275888 Preventive/Remedy for Cancer
11/29/2007US20070275882 Nature-Identical Erythropoietin
11/29/2007US20070275880 Virally-Safe Factor VIII with a Low Content of Higher Multimers
11/29/2007US20070275878 No-modified hemoglobins and uses therefor
11/29/2007US20070275873 Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting
11/29/2007US20070275872 Peptides with Anti-Obesity Activity and Other Related Uses
11/29/2007US20070275871 Epo Mimetic Peptides and Fusion Proteins
11/29/2007US20070275481 Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis
1 ... 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 ... 2916